Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
Cancer|August 2, 2018
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinomaRandall Brand, Erkut Borazanci, Virginia Speare, et al.
Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2Adriana I Apostol, Jacek Gronwald, Cezary Cybulski, et al.
Journal of the National Cancer Institute|December 17, 2025
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2Joanne Kotsopoulos, Marta Seca, Jacek Gronwald, et al.
Breast Cancer Research : BCR|October 22, 2009
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriersSusan L Neuhausen, Sean Brummel, Yuan Chun Ding, et al.
Cancer Causes & Control : CCC|July 29, 2005
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe, et al.
JAMA Oncology|February 29, 2024
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
JAMA|September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortalitySusan M Domchek, Tara M Friebel, Christian F Singer, et al.
Pageof 19